申请人:Cui Jingrong
公开号:US20050107391A1
公开(公告)日:2005-05-19
The present invention relates to compounds of the Formulae (I)-(IV), wherein R
1
-R
6
, R
11
-R
13
, X and Y are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer.
本发明涉及公式(I)-(IV)的化合物,其中R1-R6,R11-R13,X和Y在此定义,并且其药学上可接受的盐。这些化合物调节c-Met的活性,因此预计在预防和治疗c-Met相关疾病,如癌症方面有用。